#BN New mining is here again, Binance Launchpool has launched the 63rd project, using BNB and FDUSD to obtain BIO Protocol (BIO). Friends who read my article a while ago can start mining the FDUSD we exchanged at a low point. Before it ends, exchange back to USDT to capture every wave of profit. Of course, using BNB to mine will be more comfortable and yield more. Now, let us delve deeper into this project.
The BIO project is an emerging innovative project in the cryptocurrency space, focusing on the integration of biotechnology and blockchain applications. This project is dedicated to utilizing the distributed ledger, immutability, and traceability features of blockchain technology to provide new solutions for the biotechnology field. BIO aims to build an ecosystem covering multiple dimensions such as scientific research, medical care, and health data management, promoting the efficient development of the biotechnology industry and providing diverse value returns for participants.
It is worth mentioning that this project is led by women, which is very rare in the industry. Interestingly, Binance CEO CZ has stated that in the future, there will be a focus on investing in three areas: blockchain, artificial intelligence, and biotechnology. The BIO project happens to cover two of these major areas: biotechnology and blockchain.
It is foreseeable that CZ is promoting the application of blockchain globally, and its implementation will benefit humanity. In the future, the BIO project is expected to achieve the following points:
1. Users can securely upload their genetic data to the BIO platform. After encryption, research institutions can apply for authorization to use it for disease research, drug target discovery, etc. Users will receive BIO token rewards based on the frequency and value of data usage, which will both promote scientific research development and protect personal rights.
2. By combining patients' health data, genetic information, and medical history, medical institutions can customize personalized treatment plans for patients through the BIO platform. The entire process from diagnosis, medication to rehabilitation is tracked, improving treatment effectiveness, reducing medical costs, and making payment by patients more transparent and convenient.
3. Pharmaceutical companies can publish research and development project needs on the platform, collaborate with research institutions, and utilize shared biological data to screen drug targets and optimize compound structures. Smart contracts ensure fair and reasonable distribution of interests among all parties, significantly shortening the new drug development cycle and increasing the success rate.
Now let's take a look at this tokenomics chart. The initial circulation is approximately 1.3 billion. If it is below 0.5, I think it is very worthwhile to invest in.
With the rapid development of biotechnology, the demand for funding is increasing. Traditional financing methods are often inefficient and difficult to meet the urgent needs of small and medium-sized biotechnology enterprises. Therefore, the project party has adopted a fusion with blockchain to provide funding for biotechnology projects, becoming a bridge connecting the two fields and providing momentum for global biotechnology innovation.